Elanco Animal Health Inc
NYSE:ELAN
Elanco Animal Health Inc
Revenue
Elanco Animal Health Inc
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Elanco Animal Health Inc
NYSE:ELAN
|
Revenue
$4.4B
|
CAGR 3-Years
11%
|
CAGR 5-Years
8%
|
CAGR 10-Years
N/A
|
|
Johnson & Johnson
NYSE:JNJ
|
Revenue
$85.6B
|
CAGR 3-Years
1%
|
CAGR 5-Years
1%
|
CAGR 10-Years
2%
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Revenue
$45.5B
|
CAGR 3-Years
2%
|
CAGR 5-Years
14%
|
CAGR 10-Years
11%
|
|
Pfizer Inc
NYSE:PFE
|
Revenue
$55.1B
|
CAGR 3-Years
6%
|
CAGR 5-Years
8%
|
CAGR 10-Years
1%
|
|
Merck & Co Inc
NYSE:MRK
|
Revenue
$61.4B
|
CAGR 3-Years
14%
|
CAGR 5-Years
7%
|
CAGR 10-Years
3%
|
|
Eli Lilly and Co
NYSE:LLY
|
Revenue
$35.9B
|
CAGR 3-Years
12%
|
CAGR 5-Years
11%
|
CAGR 10-Years
5%
|
Elanco Animal Health Inc
Revenue Breakdown
Breakdown by Geography
Elanco Animal Health Inc
Total Revenue:
4.4B
USD
|
International:
2.4B
USD
|
United States:
2B
USD
|
Breakdown by Segments
Elanco Animal Health Inc
Total Revenue:
4.4B
USD
|
Farm Animal:
2.3B
USD
|
Pet Health:
2.1B
USD
|
Contract Manufacturing:
42m
USD
|
See Also
What is Elanco Animal Health Inc's Revenue?
Revenue
4.4B
USD
Based on the financial report for Dec 31, 2023, Elanco Animal Health Inc's Revenue amounts to 4.4B USD.
What is Elanco Animal Health Inc's Revenue growth rate?
Revenue CAGR 5Y
8%
Over the last year, the Revenue growth was 0%. The average annual Revenue growth rates for Elanco Animal Health Inc have been 11% over the past three years , 8% over the past five years .